[Experience of using thalidomide in the treatment of patients with multiple myeloma].
The results of treatment of patients with multiple myeloma with thalidomide and complications of this treatment are presented. Monotherapy with thalidomide and its combinations with corticosteroids and cytostatics is an effective as first line treatment and as a treatment of patients with refractory disease. The most common side effect is toxic neuropathy. Other complications are less common and are easily controlled with medications.
O I
OI
Novosad
I A
IA
Kriachok
T V
TV
Kadnikova
I B
IB
Tytorenko
T V
TV
Sychova
N I
NI
Kostiukova
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy*; D020258:Neurotoxicity Syndromes / Q000209:etiology; D011115:Polyneuropathies / Q000139:chemically induced; D013792:Thalidomide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D013792:Thalidomide